Nothing Special   »   [go: up one dir, main page]

Schellekens et al., 1985 - Google Patents

Interferons: past, present and future

Schellekens et al., 1985

Document ID
11256683400659289658
Author
Schellekens H
vd MEIDE P
Dijkema R
Publication year
Publication venue
Supportive therapy in haematology

External Links

Snippet

Abstract In 1935, Magrassi [1] and Hoskins [2] reported that an organism infected with a particular virus cannot be superinfected with another type of virus. This phenomenon was called viral interference. Although it is possible to explain how one type of virus can restrict …
Continue reading at link.springer.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]

Similar Documents

Publication Publication Date Title
KR100586625B1 (en) Low-toxic Human Interferon-alpha Analogs
Foster et al. Are all type I human interferons equivalent?
De Maeyer et al. Type I interferons
US4769233A (en) Structure and properties of modified interferons
JPH08504799A (en) Therapeutic combination containing interferon
CA2130230A1 (en) Sugar-modified interferon
JPH07503851A (en) Improved interferon and its production method from human peripheral blood leukocytes
US5554515A (en) Preparation of a monoclonal antibody specific to human myelomonocyte interferon-gamma
JP2005508848A6 (en) Application of consensus interferon as an inhibitor of hepatitis B surface antigen and e antigen
JPS5998019A (en) Interferon synergistic effect
De Maeyer et al. Interferons
Weinstein et al. Interferon inhibition of lymphocyte mitogenesis
JPS6154040B2 (en)
Burke The status of interferon
Marx Interferon (I): On the threshold of clinical application
Sehgal et al. Interferon and its inducers
Schellekens et al. Interferons: past, present and future
Baglioni et al. The Action of Interferon at the Molecular Level: The unique antiviral defense mechanism of interferon, a substance produced in the body in response to infection, is being studied closely for possible therapeutic applications
Schellekens et al. The chimpanzee as a model to test the side effects of human interferons
Borecký et al. Properties of the inferferon‐like virus inhibitor released during interaction of mouse sensitized lymphocytes with their target cells
EP0344643B1 (en) Antiviral pharmaceutical composition
Pitha Interferon: the 50th anniversary
Richtsmeier et al. Interferon—Present and Future Prospects
WO2000006596A2 (en) Interferon alpha hybrids
Carter et al. Independent evolution of antiviral and growth-modulating activities of interferon